ACADIA PHARMACEUTICALS INC — Form 8-K
Filed October 23, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
ACADIA Pharmaceuticals filed an 8-K on 2026-10-23 reporting Item 5.02 (officer departure, election, or compensatory arrangements). The filing document references compensatory arrangements for certain officers but the specific details—names of officers, dollar amounts, equity grants, vesting schedules, or any departures—are not included in the header metadata provided. No counterparties, dates, percentages, or share counts are disclosed in the available text.
Why this rating
Routine SEC disclosure of officer compensation or appointment. No quantified business impact disclosed; immaterial relative to $2.3B market cap.
Extracted items
See more from October 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.